Persistent hypoglycemia = glucose support required beyond 48–72 hours of life to maintain blood glucose >60 mg/dL.
Goals:
| Situation | Why It Matters |
|---|---|
| Glucose support needed beyond 48–72 hours | Meets the definition of persistent hypoglycemia — transitional hypoglycemia should have resolved |
| Frequent recurrent hypoglycemia | Suggests a persistent endocrine or metabolic disorder rather than transitional physiology |
| GIR >10 mg/kg/min | Strongly suggests hyperinsulinism or another pathologic cause — transitional hypoglycemia rarely requires this level of support |
| Hypoglycemia beyond the first week | Further increases concern for an underlying hypoglycemia disorder requiring diagnosis |
| Micropenis, undescended testes, midline defects, or recurrent hypoglycemia | Think pituitary disease (not only insulin or metabolic causes) — evaluate all pituitary axes |
History, physical examination, timing, feeding state, illness severity, and associated findings should guide the differential diagnosis before ordering tests.
Example: a newborn with micropenis and undescended testes needs pituitary evaluation — not only insulin and acylcarnitine testing.
Endocrine responses to hypoglycemia (cortisol, GH, suppression of insulin) can only be accurately interpreted during actual hypoglycemia. A normal-glucose critical sample misses the diagnostic window entirely and may falsely reassure.
| Infant Group | Target Glucose |
|---|---|
| Suspected congenital hypoglycemia disorder | >70 mg/dL |
| High-risk neonate without suspected congenital disorder (SGA, IDM) | >60 mg/dL |
| Before discharge in known genetic or persistent hypoglycemia | Consider safety fast to confirm glucose stays >70 mg/dL if a feed is missed |
Infants with known or suspected persistent hypoglycemia should not be discharged without a specialist plan, confirmed feeding schedule, outpatient monitoring plan, and ideally a completed safety fast demonstrating adequate fasting tolerance.
| Category | Examples |
|---|---|
| Insulin secretion / production disorders | Congenital hyperinsulinism, infants of diabetic mothers (prolonged), perinatal stress hyperinsulinism, erythroblastosis fetalis, Beckwith-Wiedemann syndrome |
| Endocrine abnormalities | Hypopituitarism, central adrenal insufficiency, GH deficiency, panhypopituitarism, primary adrenal insufficiency, CAH, congenital adrenal hypoplasia, adrenal hemorrhage |
| Ketogenesis and fatty-acid oxidation disorders | MCAD deficiency, other fatty-acid oxidation disorders, carnitine transport disorders, carnitine deficiency |
| Amino-acid metabolism disorders | Maple syrup urine disease, propionic acidemia, methylmalonic acidemia |
| Inborn errors of glucose production | Glycogen storage disease, gluconeogenesis disorders, pyruvate carboxylase deficiency, PEPCK deficiency, fructose-1,6-bisphosphatase deficiency, hereditary fructose intolerance |
| Bedside Clue | More Likely Diagnosis |
|---|---|
| GIR >10 mg/kg/min, low ketones, low free fatty acids | Hyperinsulinism — insulin suppresses ketone and FFA production |
| Micropenis, cryptorchidism, midline defects, hypoglycemia | Hypopituitarism, GH deficiency, ACTH deficiency |
| Hyponatremia + hyperkalemia + shock | Primary adrenal insufficiency or CAH |
| Hypoketotic hypoglycemia with illness or fasting intolerance | Fatty-acid oxidation disorder or hyperinsulinism |
| Acidosis, elevated lactate, hyperammonemia, abnormal urine organic acids | Organic acidemia or other metabolic disease |
| Hepatomegaly or fasting intolerance | Glycogen storage disease or gluconeogenesis defect |
| Test | Why It Matters |
|---|---|
| Laboratory plasma glucose | Confirms true hypoglycemia — not POCT alone |
| Serum insulin | Evaluates hyperinsulinism, but insulin alone is insufficient for diagnosis |
| Plasma beta-hydroxybutyrate | Determines whether ketones are appropriately produced (suppressed = hyperinsulinism or FAO disorder) |
| Free fatty acids | Identifies insulin effect (suppressed FFA) or fatty-acid oxidation problems |
| Plasma cortisol | Screens adrenal response during hypoglycemia |
| Growth hormone | Screens GH response during hypoglycemia |
| Glucose Value | Monitoring Action |
|---|---|
| Routine persistent hypoglycemia evaluation | Check glucose every 3 hours |
| Blood glucose <60 mg/dL | Check every 1 hour |
| Blood glucose <50 mg/dL | Send critical sample before treatment if clinically safe |
Use STAT laboratory glucose rather than POCT alone during the diagnostic evaluation. POCT has limited accuracy at low glucose values and may not accurately confirm the hypoglycemic episode needed to time sample collection.
| Test | Possible Use |
|---|---|
| C-peptide | Helps evaluate endogenous insulin secretion (C-peptide is co-secreted with insulin; absent in exogenous insulin administration) |
| Acylcarnitine profile | Screens for fatty-acid oxidation disorders (e.g., MCAD, LCHAD, VLCAD) |
| Plasma amino acids | Screens amino-acid metabolism disorders |
| Pyruvic acid | Helps evaluate disorders of energy metabolism (pyruvate carboxylase deficiency, PEPCK deficiency) |
| Ammonia and lactate | Screens organic acidemias, mitochondrial disease, and other metabolic causes |
| Urine organic acids and ketones | Identifies organic acidemias and the adequacy of ketotic response |
| Targeted gene panel | Confirms genetic hypoglycemia disorders (ABCC8, KCNJ11, GCK, GLUD1, HADH, HNF4A mutations, etc.) |
Timing should be discussed with genetics/metabolic specialists. Many of these tests (acylcarnitine profile, plasma amino acids, gene panel) do not require the patient to be hypoglycemic at the time of collection — unlike the endocrine critical sample.
Diagnosis of hyperinsulinemic hypoglycemia requires interpretation of the full critical sample:
Insulin has a very short half-life and insulin assays have poor precision at low concentrations. A "detectable" insulin level during hypoglycemia may appear normal by assay but still be inappropriately elevated for the glucose level. The ketone/FFA pattern and glucagon response are often more diagnostically useful.
| Situation | Treatment |
|---|---|
| Stable infant during planned evaluation | Obtain critical sample at plasma glucose <50 mg/dL — treat after sampling |
| Unstable infant with hypoglycemia | Treat immediately with D10W 2 mL/kg IV bolus — do not delay for sampling |
| Maintaining glucose after sampling | Start or adjust IV dextrose to maintain glucose >60 mg/dL (or >70 mg/dL if congenital disorder suspected) |
| Mistake | Better Action |
|---|---|
| Sending labs when glucose is normal | Draw the endocrine critical sample when plasma glucose is <50 mg/dL — normal-glucose samples are not diagnostic |
| Treating before obtaining a critical sample in a stable infant | If stable, draw critical sample first, then treat |
| Delaying treatment in an unstable hypoglycemic infant | If unstable, give D10W 2 mL/kg IV immediately — never delay for sampling in an unstable infant |
| Diagnosing hyperinsulinism by insulin level alone | Interpret insulin with ketones, free fatty acids, glucagon response, and clinical context |
| Ignoring physical clues | Micropenis and undescended testes should trigger pituitary evaluation — not only metabolic testing |
| Discharging persistent hypoglycemia without a specialist plan | Consider specialist consultation, safety fast, and outpatient monitoring plan before discharge |
| Using only POCT during diagnostic workup | Use STAT laboratory glucose — POCT accuracy is insufficient to time critical sample collection |
"Most newborn low blood sugar improves in the first 1–2 days, but if the baby still needs sugar supplementation after that, we need to look for a hormonal or metabolic reason."
"The best time to find the cause is during an actual low sugar episode, so we collect special blood tests before giving treatment — as long as the baby is stable enough for us to do that safely."
"If the baby is sick or unstable, we treat the low sugar right away without waiting, and gather information during the next episode."
"Before going home, some babies need a supervised fasting test to make sure blood sugar stays safe if a feeding is delayed. A specialist will help guide these decisions."